Difference in Viability of CD34+Cells in Cryopreserved Cord Blood According to Evaluation Methods.
- Author:
Mi Sun AHN
1
;
Young Woo EOM
;
Joon Seong PARK
;
Jin Hyuk CHOI
;
Seok Yun KANG
;
Hyun Woo LEE
;
Mal Sook YANG
;
Hyo Eun KIM
;
In Keun JANG
;
Jong Eun LEE
;
Young Jin KIM
;
Hugh Chul KIM
;
Seong Hyun JEONG
Author Information
- Publication Type:Original Article
- Keywords: Umbilical cord blood; Apoptosis; Viability
- MeSH: Apoptosis; Caspase 3; Cell Count; Cell Death; Cryopreservation; Diminazene; DNA; Fetal Blood; Transplants; Trypan Blue
- From:Korean Journal of Hematology 2009;44(2):92-99
- CountryRepublic of Korea
- Language:Korean
- Abstract: BACKGROUND: On performing umbilical cord blood (UCB) transplantation, faster engraftment may lead better clinical outcome. Because transplanted viable cell count in UCB is related to the engraftment, accurate evaluation of viability of CD34+cells in cryopreserved UCB has clinical implication. We examined the difference in viability of cells in cryopreserved UCB according to the duration of cryopreservation and different methods. METHODS: A total of 60 UCB samples which were cryopreserved for 1 to 4 years were used in this study. Viability of cryopreserved cells were examined with trypan blue exclusion assay, DNA contents analysis, caspase-3 activation test, intracellular esterase activity and Annexin-V/PI staining. RESULTS: After thawing the cryopreserved UCB, 89% of the total MNCs and 84% of CD34+cells were viable as identified by trypan blue exclusion assay. In the CD34+cell population, the cell death rate was found to be 47% by Annexin-V/PI staining and less than 5% by DNA contents analysis. However, cspase-3 activity failed to document apoptosis. The intracellular esterase activity test also showed a cell death rate of about 10~20% at 2, 4, and 6 hours after thawing. CONCLUSION: Viable cells in UCB should be measured by several compensatory techniques rather than a single method. Discordance among Annexin-V/PI staining versus trypan blue exclusion, DNA contents analysis, and the caspase-3 activation test or intracellular esterase activity should be clarified in order to apply these techniques for actual cord blood transplantation.
